GEISTLICH PHARMA
Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.
GEISTLICH PHARMA
Industry:
Biotechnology Health Care Medical
Founded:
1851-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.geistlich-pharma.com
Total Employee:
501+
Status:
Active
Contact:
(855) 799-5500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager Font Awesome Apache Amazon Google Maps JsDelivr Cloudflare JS
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Official Site Inspections
http://www.geistlich-pharma.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.84 K
- Host name: gate64.pd056.proserver.punkt.de
- IP address: 138.201.149.158
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Geistlich Pharma"
About Us - Geistlich Pharma AG
The Swiss MedTech company Geistlich develops, produces and distributes medical products for the regeneration of bone, cartilage and tissue. IN ACTION FOR REGENERATION Our โฆSee details»
Our Company - Geistlich Pharma AG
Geistlich Pharma AG Bahnhofstrasse 40 CH - 6110 Wolhusen. Phone: +41 41 492 55 55 Fax: +41 41 492 56 39 [email protected]. ... As part of the Geistlich Group, we develop, produce โฆSee details»
Geistlich USA: Company
Geistlich Pharma North America Inc. 400 Alexander Park Drive, Suite 302 Princeton, NJ 08540 USA. Geistlich Dental Customer Care Phone: 855-799-5500 (Toll-free) Geistlich Medical (Advanced Wound Care | Surgical and Sports โฆSee details»
Geistlich Pharma - Crunchbase Company Profile & Funding
Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has โฆSee details»
Informs you even better โ the new website of Geistlich โฆ
Apr 7, 2014 The new website of Geistlich Pharma AG has been live since today. With the re-launch, the information content has been tailored even more specifically to the information โฆSee details»
Geistlich Pharma North America, Inc. - The Org
Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and โฆSee details»
Geistlich Pharma | LinkedIn
Geistlich Pharma | 13.028 Follower:innen auf LinkedIn. Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, โฆSee details»
Geistlich Pharma AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Geistlich Pharma AG of Wolhusen, LUZERN. Get the latest business insights from Dun & Bradstreet.See details»
About Us - Geistlich Pharma AG
Geistlich Sons Limited Thorley House, Bailey Lane, Manchester Airport, GB - Manchester M90 4AB. Phone: +44 161 490 2038 Fax: +44 161 498 6988 ... Geistlich Pharma Our Company โฆSee details»
Geistlich Pharma AG - Swiss Biotech
Geistlich Pharma is specialized in biomaterials for the regeneration of bone, cartilage and tissue and develops and manufactures medical devices and pharmaceuticals with the goal of giving โฆSee details»
Geistlich Pharma - Overview, News & Similar companies
Who is Geistlich Pharma. Geistlich's regenerative medical devices aim to improve patients' quality of life. More than 750 employees worldwide work for Geistlich in the area of regenerative โฆSee details»
Geistlich Pharma Company Profile - Office Locations ... - Craft
Geistlich Pharma is a producer, developer, and distributor of medical devices and drugs. It offers biomaterials, dental, surgical orthopedics, sports and spinal medicine, dentistry, oral, โฆSee details»
Geistlich Pharma - Funding, Financials, Valuation
Geistlich Pharma has acquired 2 organizations. Their most recent acquisition was Bionnovation Biomedical on Apr 5, 2024. Which types of acquisition does this organization make most โฆSee details»
Geistlich USA: United States
Geistlich Pharma North America Inc. 400 Alexander Park Drive, Suite 302 Princeton, NJ 08540 USA. Geistlich Dental Customer Care Phone: 855-799-5500 (Toll-free) Geistlich Medical โฆSee details»
Geistlich Pharma North America - Overview, News
Mar 15, 2023 Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide โฆSee details»
Geistlich Pharma partners with StimLabs for wound care โฆ
1 day ago Geistlich Pharma has entered an exclusive national distribution collaboration agreement with StimLabs in the US, focusing on the commercialisation of the formerโs โฆSee details»
Our History - Geistlich Pharma AG
In 2013, Dr. Peter Geistlich and Geistlich Pharma launched the Osteo Science Foundation based in the US. Its declared goal is to support independent basic and applied research and enable โฆSee details»
Geistlich Pharma North America, Inc. acquires Lynch โฆ
Oct 26, 2022 For Immediate Release: Princeton, New Jersey October 26, 2022: Geistlich Pharma North America announced today the acquisition of Lynch Biologics, LLC, the โฆSee details»
Nivolumab in Patients With Advanced or Metastatic โฆ
3 days ago PURPOSETo report on CheckMate 627 (ClinicalTrials.gov identifier: NCT02832167), a phase II adaptive basket design trial of nivolumab in uncommon advanced/metastatic โฆSee details»
Impressive results for Geistlich Pharma in 2020 despite โฆ
Mar 22, 2021 Associated with the measures introduced worldwide to optimize costs and achieve greater flexibility, Geistlichโs very good annual results in 2020 are impressive given the โฆSee details»